TABLE 1

Patient characteristics for laboratory-reported C. striatum compared to Staphylococcus spp. in clinical specimensa

CharacteristicbCorynebacterium striatum (n = 256)Coagulase-negative Staphylococcus (n = 1,537)Staphylococcus aureus (n = 2,655)
No.%No.%No.%
Sex
    Male14155.185255.431,46955.33
    Female11544.968544.571,18644.67
Age (yr)
    <2031.2181.17391.47
    20–29155.91238.0034512.99
    30–39197.41489.6327210.24
    40–492610.218812.2335513.37
    50–596525.432621.2153320.08
    60–697228.137924.6657821.77
    70–793614.123715.4235313.30
    80–89166.3976.311606.03
    >9041.6211.37200.75
Source
    Wound6726.218011.7144916.91
    Respiratory6123.830.2045517.14
    Tissue (lymph node)3614.1785.071806.78
    Bone3011.7221.43371.39
    Blood239.066943.5338114.35
    LVAD72.750.3370.26
    Urine31.229619.261415.31
    Other, sterilec145.521113.7334813.11
    Other, nonsteriled155.9734.7565724.75
  • a All isolates were isolated from clinical samples from 1 January 2013 to 31 December 2015.

  • b LVAD, left ventricular assist device.

  • c Includes aspirate, biopsy, catheter tip, cerebrospinal fluid, hardware, joint fluid, pleural fluid, peritoneal fluid, shunt, stones, synovial fluid, and valve specimens.

  • d Includes cervical, cyst, cornea, drainage, genital, lesion, ocular swab, placenta, sinus, stool, ulcer, urethra, vaginal, vesicle, and wound specimens.